Status:
ACTIVE_NOT_RECRUITING
The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Overdose
Risk Behavior
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In the setting of naloxone standing orders, this study will assess the impact of a targeted, web-based overdose prevention and naloxone intervention for patients prescribed chronic opioid therapy. Out...
Detailed Description
This is a patient level randomized study of a targeted, web-based overdose prevention and naloxone intervention for patients prescribed chronic opioid therapy. This study will be conducted in a health...
Eligibility Criteria
Inclusion
- 18 years of age or greater
- Prescribed chronic opioid therapy
- Have a health plan which covers the formulation of naloxone available at the pharmacy they received their opioid prescriptions from.
Exclusion
- Non-English speaking, hospice enrollment, do-not-resuscitate order, no internet access
Key Trial Info
Start Date :
December 21 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
1004 Patients enrolled
Trial Details
Trial ID
NCT03337009
Start Date
December 21 2017
End Date
June 30 2024
Last Update
May 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Colorado
Denver, Colorado, United States, 80231